Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Purity > 98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory

Lus piav qhia luv luv:

Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate

CAS: 205448-66-4 Nr

Purity:> 98.0% (HPLC)

Cov tsos mob: Tawm-dawb mus rau daj hmoov hmoov

Intermediate ntawm Lenvatinib Mesylate CAS 857890-39-2

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate
Synonyms Lenvatinib impurity 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D
CAS Nr 205448-66-4
CAT Number RF-PI 1970
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C12H10ClNO3
Molecular Luj 251.67 ib
Boiling Point 377.4 ± 37.0 ℃
Qhov ntom 1.320 ± 0.06g / cm3
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Off-White to Yellow Solid Powder
1 H NMR Spectrum Raws li tus qauv
Purity / Analysis Method > 98.0% (HPLC)
Poob rau ziab <1.00%
Tag nrho cov impurities <2.00%
Test Standard Enterprise Standard
Kev siv Intermediate / Impurity ntawm Lenvatinib Mesylate (CAS: 857890-39-2)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) yog ib qho nruab nrab ntawm Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib yog cov tshuaj kho mob qog noj ntshav uas tsim los ntawm Eisai Corporation ntawm Nyiv (Code: E7080), koom nrog inhibitor ntawm qhov ncauj ntau tus neeg txais tyrosine kinase (RTK) thiab tuaj yeem cuam tshuam kinase kev ua ntawm vascular endothelial kev loj hlob yam Receptors R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Lenvatinib tseem tuaj yeem cuam tshuam kev koom tes ntawm lwm cov RTKs hauv pathological angiogenesis, qog loj hlob, thiab kev mob qog noj ntshav tshwj tsis yog rau lawv cov kev ua haujlwm ntawm tes xws li fibroblast kev loj hlob (FGF) receptors FGFR1, 2, 3, thiab 4;platelet-derived growth factor receptor (PDGFR [alpha]), KIT, thiab RET.[Cov Lus Qhia]: Lenvatinib yog qhov tsim nyog rau kev kho mob ntawm cov neeg mob qog nqaij hlav qog noj ntshav hauv zos lossis hom metastasis, hom kev nce qib thiab hom xov tooj cua iodine-refractory txawv.

Sau koj cov lus ntawm no thiab xa tuaj rau peb